investor.ifscapthai.com
IFS Capital (Thailand) Public Company Limited
Hotline : (66)2 285 6326 - 32. Compensation and Normination Committee. Leasing / Hire Purchase. IFS Capital (Thailand) Public Company Limited (IFS) is an established financial institution and the leader in providing factoring services in Thailand. It is well-known and widely accepted in Thailand. With over 23 years of establishment, you can trust our excellent service and stability. Financial Statement Quarter 3/2016. Reviewed Quarter 3 F/S (F45-1). Updated: 12 January 2017 16:37. Go to Stock Chart.
investor.ifunding.com
iFunding Investor Portal
investor.igg.com
Company Profile - About IGG – Investor
The Group is a rapidly growing developer and publisher of mobile online games with a global presence and international customer base. The Group has its headquarter in Singapore with regional offices in the United States, China, Canada, Japan, Korea, Thailand and the Philippines, with customers from over 200 countries and regions around the world. Please choose your server.
investor.ignyta.com
Investors - Ignyta, Inc.
4:00 PM ET on Aug 14, 2015. Delayed at least 20 minutes. Aug 10, 2015. Ignyta Announces Second Quarter 2015 Company Highlights and Financial Results. Aug 5, 2015. Ignyta to Report 2015 Second Quarter Company Highlights and Financial Results and Host Conference Call on August 10, 2015. View all press releases ». Aug 10, 2015 at 4:30 PM ET. Ignyta Inc. Second Quarter 2015 Financial Results Conference Call. Jul 8, 2015 at 3:00 PM ET. Cantor Fitzgerald Inaugural Healthcare Conference.
investor.igo.com
iGo | Investor Relations
investor.ihs.com
IHS - Investor Relations - Investor Relations
Obtain the data you need to make the most informed decisions by accessing our extensive portfolio of information, analytics, and expertise. Sign in to the product or service center of your choice. Https:/ my.ihsenergy.com/. Https:/ login.ihserc.com/login/erc? UK Solutions (including CIS/OHSIS). Https:/ www.ihsti.com/ihsti/index.aspx. Http:/ connect.ihs.com/. Economics and Country Risk. Engineering Knowledge and Tools. Environmental, Health and Safety. Market Insight, Forecasts and Company Analysis. Jun 2...
investor.ihsmarkit.com
Investor Relations | Investors | IHS
Stock Quote and Chart. Merger Information and Documents. Q4 2016 IHS Markit Earnings Conference Call. January 17, 2016. IHS Markit Reaffirms 2016 Guidance, Provides 2017 Guidance. November 14, 2016. IHS Markit 2016 Guidance Call Supplemental Materials. July 13, 2016. IHS Markit is a new global information leader. July 13, 2016. IHS and Markit Complete Merger to Form Global Information Powerhouse. July 12, 2016. January 11, 2017 4:00 pm ET. IHS Markit Share Related. 15,513,263,000. Click here for webcast.
investor.illumina.com
Illumina .::. Investor Relations Overview
Illumina Accelerator Invests in Second Class of Genomics Startups from US and Europe. Illumina Signs Agreement to Acquire GenoLogics, Leader in Genomics Laboratory Information Management System Market. Illumina Reports Financial Results for Second Quarter of Fiscal Year 2015. Illumina Names Sanjay Chikarmane as Senior Vice President and General Manager of Enterprise Informatics. Illumina Introduces Illumina SeqLab. Q2 2015 Illumina, Inc. Earnings Conference Call. 160; 0.84. Data as of 08/07/15 4:00 pm ET.
investor.immucor.com
Investor Relations | Immucor, Inc. – IR Site
Skip to main navigation. China (ä æ ). Japan (æ æœ èªž). Vision, Mission and Values. Reagent Red Blood Cells. Founded in 1982 and based in Norcross, GA, Immucor is a global leader in transfusion and transplantation diagnostics that facilitate patient/donor compatibility. Our mission is to ensure that patients in need of blood, organs, or stem cells get the right match that is safe, accessible, and affordable. Jan 16, 2018. Avi Pelossof Appointed President and CEO of Immucor. Jul 26, 2017.
investor.immunogen.com
Investors | ImmunoGen, Inc.
Skip to main navigation. What is an ADC? What is an ADC? And in programs in development by Amgen, Bayer, Biotest, CytomX, Debiopharm, Lilly, Novartis, Sanofi and Takeda. More information about the Company can be found at www.immunogen.com. Mar 24, 2018. ImmunoGen Presents Data from FORWARD II Assessment of Mirvetuximab Soravtansine in Combination with Pembrolizumab at the Society of Gynecologic Oncology Annual Meeting. Mar 14, 2018. May 9, 2018 at 9:20 AM EDT. May 9, 2018. There are no items to display.
investor.impinj.com
IMPINJ | Investor Relations
01/11/17 4:00 pm ET. Data Provided by Nasdaq. Minimum 15 minutes delay. Impinj to Present at Needham Growth Conference. Impinj, Inc. Announces Closing of Follow-On Public Offering and Full Exercise of the Underwritersâ Option to Purchase Additional Shares. Impinj, Inc. Announces Pricing of Follow-On Public Offering. There are currently no events scheduled. Chat with us on social media.
SOCIAL ENGAGEMENT